Pharma majors Sanofi and GSK on Tuesday said they have joined hands to develop a vaccine for COVID-19. The companies in a joint statement said they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both firms, to help address the ongoing pandemic.